NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several major companies. Notable changes include NVIDIA's price target increase by Wells Fargo, despite a recent share price drop. Other companies like PVH, CrowdStrike, and Salesforce also saw target adjustments.
August 29, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rosenblatt lowered CrowdStrike's price target from $330 to $325, maintaining a Buy rating. Shares fell 2.1% to $264.20.
The slight reduction in price target and share price drop may indicate short-term negative sentiment for CrowdStrike.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Morgan Stanley cut Equinor's price target from $30.5 to $25.8, downgrading from Equal-Weight to Underweight. Shares closed at $27.10.
The significant price target cut and downgrade to Underweight suggest a negative short-term outlook for Equinor.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
B of A Securities cut PVH's price target from $133 to $130, maintaining a Buy rating. PVH shares fell 6.4% to $97.75.
The reduction in price target and significant share price drop suggest potential short-term negative sentiment for PVH.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEUTRAL IMPACT
Loop Capital raised Salesforce's price target from $240 to $270, maintaining a Hold rating. Shares fell 2% to $258.90.
Despite the price target increase, the Hold rating and share price drop suggest a neutral short-term outlook for Salesforce.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEUTRAL IMPACT
UBS raised HP's price target from $34 to $37, maintaining a Neutral rating. Shares fell 2.4% to $34.76.
The price target increase with a Neutral rating suggests a balanced short-term outlook for HP, despite the share price drop.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Piper Sandler boosted Neurocrine Biosciences' price target from $131 to $159, upgrading from Neutral to Overweight. Shares fell 18.9% to $123.76.
The significant price target increase and upgrade to Overweight suggest a positive outlook for Neurocrine Biosciences, despite the large share price drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Wells Fargo raised NVIDIA's price target from $155 to $165, maintaining an Overweight rating. Despite this, NVIDIA shares fell 2.1% to $125.61.
The increase in price target by Wells Fargo suggests a positive outlook for NVIDIA, which could lead to a short-term price increase despite the recent drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Williams Trading raised Shoe Carnival's price target from $42 to $51, maintaining a Buy rating. Shares fell 6.1% to $40.47.
The significant price target increase and Buy rating suggest a positive outlook for Shoe Carnival, despite the recent share price drop.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Evercore ISI Group increased Spotify's price target from $420 to $460, maintaining an Outperform rating. Shares fell 0.6% to $337.56.
The increase in price target and Outperform rating suggest a positive short-term outlook for Spotify, despite the slight share price drop.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Baird boosted Veeva Systems' price target from $245 to $251, maintaining an Outperform rating. Shares fell 0.5% to $199.35.
The increase in price target and Outperform rating suggest a positive short-term outlook for Veeva Systems, despite the slight share price drop.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100